College of Nursing, University of Saskatchewan, Saskatoon, Saskatchewan.Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Study Type - Decision analysis (lacking sensitivity analysis) Level of Evidence 4.
What's known on the subject? and What does the study add? Active surveillance is a management strategy that offers patients the hope of avoiding the side effects associated with unnecessary treatment. This study identifies the resources required by men who choose to be on active surveillance to support them in their treatment decision.
To examine the decision-making processes of men on active surveillance (AS). To identify the resources that men want to access to make, support and sustain them while on AS.
Three-part survey developed for this study based on a qualitative study of 25 men on AS. Survey items explored: role men assumed with their physician in treatment decision-making, factors influencing decision to go on AS, and resources required while on AS. Surveys mailed out to cross-sectional sample of men on AS for less than 10 years.
27% of the 73 men reported assuming an active role in treatment decision-making with their urologist, 41% a shared role and 32% a passive role. 82% of men reported being comfortable and 90% being satisfied with their decision to be on AS. 55% reported not being anxious about the cancer progressing while on AS. Urologist's opinion, current age, and impact of treatment on urinary function were main factors influencing treatment decision. Information on future treatment options, non-traditional treatments and diet considered most important resources.
Results suggest that once men make a decision to go on AS, they are satisfied with their decision and few report being anxious about progression of cancer. Men are strongly influenced by the treating specialist in taking up AS. Additional information and psychological support resources are required for men on AS.
Davison BJ, Goldenberg SL. Are you the author?
Reference: BJU Int. 2011 Apr 20. Epub ahead of print.